SCHEMBL2154313

SCHEMBL2154313

CC(C)(C)NNC(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12179889 0.75
SCHEMBL12527323 0.71
SCHEMBL7153698 0.71
SCHEMBL22784095 0.69
SCHEMBL49720 0.62
SCHEMBL4802647 0.62
SCHEMBL49646 0.62
Water SCHEMBL23525631 0.59
SCHEMBL189693 0.59
Hydrochloric Acid SCHEMBL4467690 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180155827-A1 Synthesis of Metal Nitride Thin Films Materials using Hydrazine Derivatives APPLIED MATERIALS, INC. 2018-06-07 US claimed
US-12622232-B2 Advanced self aligned multiple patterning using tin oxide LAM RESEARCH CORPORATION (US) 2026-05-05 US disclosed
US-20260090293-A1 SEMICONDUCTOR STACKS AND PROCESSES THEREOF LAM RES CORP (US) 2026-03-26 US disclosed
US-12588475-B2 High selectivity doped hardmask films LAM RESEARCH CORPORATION (US) 2026-03-24 US disclosed
US-20260076110-A1 HYBRID ATOMIC LAYER DEPOSITION LAM RES CORP (US) 2026-03-12 US disclosed
US-20260047361-A1 METHOD AND APPARATUS FOR ATOMIC LAYER DEPOSITION USING MULTIPLE CHAMBERS NATIONAL TSING HUA UNIVERSITY (TW) 2026-02-12 US disclosed
EP-4651192-A2 UNDERLAYER FOR PHOTORESIST ADHESION AND DOSE REDUCTION Lam Research Corporation (US) 2025-11-19 EP disclosed
US-12474638-B2 Underlayer for photoresist adhesion and dose reduction LAM RESEARCH CORPORATION (US) 2025-11-18 US disclosed
US-20250328076-A1 UNDERLAYER FOR PHOTORESIST ADHESION AND DOSE REDUCTION LAM RES CORP (US) 2025-10-23 US disclosed
US-20250283221-A1 CARRIER RING WITH TABS LAM RES CORP (US) 2025-09-11 US disclosed
EP-2519532-A1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS Chevron Phillips Chemical Company LP (US) 2012-11-07 EP disclosed
US-8288538-B2 Pyridine derivatives and pyrimidine derivatives (3) EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-10-16 US disclosed
WO-2011130397-A2 IMPROVED SILICON NITRIDE FILMS AND METHODS NOVELLUS SYSTEMS, INC. (US) 2011-10-20 WO disclosed
US-20110256734-A1 SILICON NITRIDE FILMS AND METHODS NOVELLUS SYSTEMS, INC. 2011-10-20 US disclosed
WO-2011082192-A1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2011-07-07 WO disclosed
US-20100075944-A1 NOVEL PYRIDINE DERIVATIVES AND PYRIMIDINE DERIVATIVES (3) MATSUSHIMA TOMOHIRO 2010-03-25 US disclosed
US-5691419-A ACRYLATED RESIN POLYSILOXANES FOR COATINGS BASF LACKE + FARBEN, AG (DE) 1997-11-25 US disclosed
US-5686531-A ACRYLATED POLYSILOXANE MACROMONOMER BASF LACKE + FARBEN, AG (DE) 1997-11-11 US disclosed
US-3957750-A SYMMETRICAL BIS(UNSYMMETRICAL TERTIARY-ALKYL AND TERTIARY-ARALKYL AZO) COMPOUNDS PENNWALT CORPORATION (US) 1976-05-18 US disclosed
US-3937761-A SYMMETRICAL BIS(UNSYMMETRICAL TERTIARY-ALKYL AND TERTIARY- ARALKYL AZO) COMPOUNDS PENNWALT CORPORATION (US) 1976-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12588475-B2 High selectivity doped hardmask films PRP4K, ITGAV, PRPF3 MEN1 1228/4885KMT2A 957/4885
US-20260047361-A1 METHOD AND APPARATUS FOR ATOMIC LAYER DEPOSITION USING MULTIPLE CHAMBERS FBL, EXOSC9, SAMM50 MEN1 1464/4885KMT2A 1021/4885
US-12622232-B2 Advanced self aligned multiple patterning using tin oxide SMCHD1, NOTCH3, NOTCH2 MEN1 627/4885KMT2A 1106/4885
US-20260090293-A1 SEMICONDUCTOR STACKS AND PROCESSES THEREOF PRPF3, PRPF4, MTREX MEN1 1923/4885KMT2A 1083/4885
US-20260076110-A1 HYBRID ATOMIC LAYER DEPOSITION NOS2, SFN, DSTYK MEN1 3073/4885KMT2A 596/4885
US-20100075944-A1 NOVEL PYRIDINE DERIVATIVES AND PYRIMIDINE DERIVATIVES (3) HGF, MET, HDGF MEN1 3868/4885KMT2A 4123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.